Regulated Information

In accordance with French legislation, these pages provide access to all regulated information published by Sartorius Stedim Biotech as defined by the French Market Authority (AMF, Autorités des Marchés Financiers).

Furthermore, the Related-party agreements entered into by Sartorius Stedim Biotech are presented below pursuant to Article L. 225-40-2 of the French Commercial Code. 


Reports since 2009

Reports since 2009

Reports since 2009

Fees Received by Statutory Auditors since 2009

Voting rights and share making up the issued capital





More Information

Investor Relations Sartorius Stedim Biotech SA

Learn More

Shareholders' Meeting

Learn More

Sartorius Stedim Biotech Share

Learn More